REV1 and cancer: Because REV1 functionally links DSBR with enhanced mutations and REV1 inhibitors suppress apoptosis and trigger senescence to sensitize cancer cells to chemotherapy [8,11,12], it is unknown whether REV1 may similarly sensitize cancer cells to radiation therapy and prevent radioresistance.